A review of diagnostic imaging in melanoma

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 61, Issue 11, 2008, Pages 1275-1283

  Dancey, A L ^a   Mahon, B S ^b   Rayatt, S S ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Follow up; Guidelines; Imaging; Melanoma; Radiology

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOISOTOPE; TECHNETIUM 99M;

COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; COST; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKELETON; THORAX RADIOGRAPHY;

COSTS AND COST ANALYSIS; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MELANOMA; POSITRON-EMISSION TOMOGRAPHY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 53349103863     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2008.04.034     Document Type: Review

References (65)

1. Balch C.M., Soong S.J., Murand T.M., et al. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastasis (stage III). J Clin Oncol 1 (1982) 126-133
2. Lee M.L., Tomsu K., and Von Eschan K.B. Duration of survival for disseminated malignant melanoma. Results of a meta-analysis. Melanoma Res 10 (2000) 81-92
3. Patel J.K., Didolkar M.S., Pickren J.W., et al. Metastatic pattern of malignant melanoma: a study of 216 autopsy cases. Am J Surg 135 (1978) 807-810
4. Fleming I.D., Cooper J.S., Heaston D.E., et al. Purposes and principals of staging. AJCC cancer staging manual (1997), Lippincott - Raven, Philadelphia 3-9
5. Balch C.M., Buzaid A.C., Soong S.J., et al. Final version of the American joint committee on cancer staging system forcutaneous melanoma. J Clin Oncol 19 (2001) 3635-3648
6. Baddeley H. Radiological investigation. A guide to the use of medical imaging in clinical practice (1984), Wiley Medical Publications
7. Terhune M.H., Swanson N., and Johnson T.M. Use of chest radiography in the initial evaluation of patients with localised melanoma. Arch Dermatol 134 (1998) 569-572
8. Hofmann U., Szedlak M., Rittgen W., et al. Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival. Br J Cancer 87 (2002) 151-157
9. Harland C.C., Kale S.G., Jackson P., et al. Differentiation of common benign pigmented skin lesions from melanoma by high-resolution ultrasound. Br J Dermatol 143 (2000) 281-289
10. Bessoud B., Lassau N., Koscielny S., et al. High-frequency sonography and color Doppler in the management of pigmented skin lesions. Ultrasound Med Biol 29 (2003 Jun) 875-879
11. Garbe C., Paul A., Kohler-Spath H., et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol 21 (2003) 520-529
12. Machet L., Nemeth-Normand F., Giraudeau B., et al. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients. Br J Dermatol 152 (2005) 66-70
13. Saiag P., Bernard M., Beauchet A., et al. Ultrasonography using simple diagnostic criteria vs palpation for the detection of regional lymph node metastases of melanoma. Arch Dermatol 141 (2005) 183-189
14. Kahle B., Hoffend J., Wacker J., et al. Preoperative ultrasonographic identification of the sentinel lymph node in patients with malignant melanoma. Cancer 97 (2003) 1947-1954
15. Deurloo E.E., Tanis P.J., Gilhuijs K.G., et al. Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 39 (2003) 1068-1073
16. Rossi C.R., Mocellin S., Scagnet B., et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol 83 (2003) 80-84
17. Hocevara M., Brackob M., Pogacnikc A., et al. The role of preoperative ultrasonography in reducing the number of sentinel lymph node procedures in melanoma. Melanoma Res 14 (2004) 533-536
18. Ardizzoni A., Grimaldi A., Repetto L., et al. Stage I-II melanoma: the value of metastatic work-up. Oncology 44 (1987) 87-89
19. Armstrong P. Chest. In: Armstrong P., and Wastie M.L. (Eds). A concise textbook of radiology (2001), Arnold, London, UK 536-594
20. Halton K.P. Radiological considerations in diagnosis of metastatic melanoma. Mt Sinai J Med 59 (1992) 211-216
21. Heaston D.K., Putman C.E., Rodan B.A., et al. Solitary pulmonary metastasis in high risk melanoma patients: a prospective comparison of conventional and computed tomography. AJR Am J Roentgenol 141 (1983) 169-174
22. Finkelstein S.E., Carrasquillo J.A., Hoffman J.M., et al. A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy. Ann Surg Oncol 11 (2004) 731-738
23. Buzaid A.C., Tinoco L., Ross M.I., et al. Role of computed tomography in staging of patients with local-regional metastases of melanoma. J Clin Oncol 13 (1995) 2104-2108
24. Jonhson T.M., Fader P.J., Chang A.E., et al. Computed tomography in staging of patients with melanoma metastatic to regional lymph nodes. Ann Surg Oncol 4 (1997) 396-402
25. Miranda E.P., Gertner M., Wall J., et al. Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease. Arch Surg 139 (2004) 831-837
26. Aloia T.A., Gershenwald J.E., Andtbacka R.H., et al. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma. J Clin Oncol 24 (2006 Jun 20) 2858-2865
27. Muller-Horvat C., Radny P., Eigentler T.K., et al. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer 42 (2006) 342-350
28. Lauenstein T.C., Goehde S.C., Herborn C.U., et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology 233 (2004 Oct) 139-148
29. Armstrong P., Haenaur J.M., Rezneck R.H., et al. Imaging techniques. In: Armstrong P., and Wastie M.L. (Eds). A concise textbook of radiology (2001), Arnold, London (UK) 1-16
30. Macapinlac H.A. The utility of 2-deoxy-2-fluro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanoma. Mol Imaging Biol 6 (2004) 200-207
31. Hafner J., Schmid M.H., Kempf W., et al. Baseline staging in cutaneous malignant melanoma. Br J Dermatol 150 (2004) 677-686
32. Clark P.B., Soo V., Kraas J., et al. Futility of fluorodeoxyglucose F18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Arch Surg 141 (2006) 284-288
33. Rinne D., Baum R.P., Hor G., et al. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients. Cancer 82 (1998) 1664-1671
34. Prichard R.S., Hill A.D., Skehan S.J., et al. Positron emission tomography for staging and management of malignant melanoma. Br J Surg 89 (2002 Apr) 389-396
35. Tyler D.S., Onaitis M., Kherani A., et al. Positron emission tomography scanning in malignant melanoma. Cancer 89 (2000) 1019-1025
36. Gulec S.A., Faries M.B., Lee C.C., et al. The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making. Clin Nucl Med 28 (2003) 961-965
37. Wagner J.D. A role for FDG-PET in the surgical management of stage IV melanoma. Ann Surg Oncol 11 (2004) 721-722
38. Acland K.M., Healy C., Calonje E., et al. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastasis of primary cutaneous malignant melanoma. J Clin Oncol 19 (2001) 2674-2678
39. Wagner J.D., Schauwecker D., Davidson D., et al. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. J Clin Oncol 17 (1999) 1508-1515
40. Havenga K., Cobben D.C., Oyen W.J., et al. Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. Eur J Surg Oncol 29 (2003) 662-664
41. Fink A.M., Holle-Robatsch S., Herzog N., et al. Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II. Melanoma Res 14 (2004) 141-145
42. Wagner J.D., Schauwecker D., Davidson D., et al. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma. Cancer 104 (2005) 570-579
43. Franc B.L., Mari C., Johnson D., et al. The role of a positron- and high-energy gamma photon probe in intraoperative localization of recurrent melanoma. Clin Nucl Med 30 (December 2005) 787-791
44. Pfannenberga C, Aschoff P, Schanza S, Eschmannb SM, Plathowa C, Eigentlerc TK, Garbec C, Brechtela K Vontheind R, Baresb R, Claussena CD, Schlemmera HP, Prospective comparison of 18F-fluorodeoxyglucosepositron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 43 (25207) 557-564.
45. Von Schulthess G.K., Steinert H.C., and Hany T.F. Integrated PET/CT: current applications and future directions. Radiology 238 (Feb 2006)
46. Reinhardt M.J., Joe A.Y., Jaeger U., et al. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol 24 (2006) 1178-1187
47. Iagaru A., Quon A., Johnson D., et al. 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma. Mol Imaging Biol 8 (2006) 309-314
48. Schoder H., Larson S.M., and Yeung H.W. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med 45 (2004)
49. Blodgett T.M., Meltzer C.C., and Townsend D.W. PET/CT: form and function. Radiology 242 (2007 Feb) 360-385
50. Strobel K., Dummer R., Husarik D.B., et al. Steinert HC High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases. Radiology 244 (2007 Aug) 566-574
51. Au F.C., Marier W.P., Malmud L.S., et al. Preoperative nuclear scans in patients with melanoma. Cancer 59 (1984) 2095-2097
52. Uren F.R., Howman-Giles R., Chung D., et al. Nuclear Medicine Aspects of melanoma and breast lymphatic mapping. Semin Oncol 31 (2004) 338-348
53. Gershenwald J.E., Thompson W., Mansfield P.F., et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17 (1999) 976-986
54. Hettiaratchy S.P., Kang N., O'Toole G., et al. Sentinel lymph node biopsy in malignant melanoma: a series of 100 consecutive patients. Br J Plast Surg 53 (2000 Oct) 559-562
55. Morton D.L., Cochran A.J., Thompson J.F., et al. Multicenter selective lymphadenectomy trial group. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242 (2005 Sep) 302-311
56. Essner R., Scheri R., Kavanagh M., et al. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. Arch Surg 141 (2006 Sep) 877-882
57. Morton D.L., Thompson J.F., Cochran A.J., et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355 (2006 Sep 28) 1307-1317
58. Reinus W.R. American radiology and outsourcing. Radiology 242 (2007 Mar) 654-657
59. Hollingworth W. Radiology cost and outcomes studies: standard practice and emerging methods. AJR Am J Roentgenol 185 (2005 Oct) 833-839
60. http://www.dh.gov.uk/refcosts
61. http://www.cms.hhs.gov/PFSlookup/02_PFSSearch.asp (accessed 04.11.07)
62. Hofmann U., Szedlak M., Rittgen W., et al. Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival. Br J Cancer 87 (2002 Jul 15) 151-157
63. Newton Bishop J.A., Corrie P.G., Evans J., et al. UK guidelines for the management of cutaneous melanoma. Br J Plast Surg 55 (2002) 46-54
64. Sober A.J., Chuang T.Y., Duvic M., et al. Guideline of care for primary cutaneous melanoma. J Am Acad Dermatol 45 (2001) 579-586
65. Poo-Hwu W.-J., Ariyan S., Lamb L., et al. Follow-up recommendations for patients with American Joint Committee on Cancer stages I-III malignant melanoma. Cancer 86 (1999) 2252-2258